NERVGEN PHARMA CORP. Financial Assets Measured At Fair Value Through Other Comprehensive Income
NERVGEN PHARMA CORP. (NGEN) had Financial Assets Measured At Fair Value Through Other Comprehensive Income of CAD 0 as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome · last filed 2026-03-31
- 2025-12-31: Financial Assets Measured At Fair Value Through Other Comprehensive Income 0.00 CAD.
| Period end | Financial Assets Measured At Fair Value Through Other Comprehensive Income |
|---|---|
| 2025-12-31 | 0.00 CAD 40-F · filed 2026-03-31 |